{"id":5363,"date":"2020-01-09T13:11:11","date_gmt":"2020-01-09T18:11:11","guid":{"rendered":"https:\/\/www.bu.edu\/neidl\/?page_id=5363"},"modified":"2024-04-03T12:30:14","modified_gmt":"2024-04-03T16:30:14","slug":"about-neidl","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/neidl\/about-neidl\/","title":{"rendered":"About"},"content":{"rendered":"<p><strong>Following the events of September 11, 2001, the lack of available and adequate research facilities was determined to be a major impediment to the study of emerging infectious diseases. Important pathogens had received little research attention, and many had not been examined using the tools of modern science.<\/strong><\/p>\n<p><strong>In 2003, Boston University was awarded a grant from the <a title=\"http:\/\/www.niaid.nih.gov\/\" href=\"http:\/\/www.niaid.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">National Institute of Allergy and Infectious Diseases<\/a> (NIAID) to build one of two National Biocontainment Laboratories. Supporting NIAID\u2019s newly developed research agenda, the National Emerging Infectious Diseases Laboratories (NEIDL) represents a major step forward in advancing public health and solidifying the New England area\u2019s reputation as the biomedical research hub of the nation.<\/strong><\/p>\n<h5>For more history and background on NEIDL, <a href=\"http:\/\/www.bu.edu\/neidl\/resources\/\">click here<\/a>.<\/h5>\n<h2 align=\"center\">Threading the NEIDL<\/h2>\n<h3>NEIDL and its staff maintain its laboratories to support research in a safe and secure environment. The facility was designed and constructed with the highest level of attention to community and laboratory safety and security.<\/h3>\n<p>The National Emerging Infectious Diseases Laboratories (NEIDL) is a state-of-the-art research facility that supports the work of investigators who focus on infectious diseases that are\u2014or have the potential to become\u2014major public health concerns. Our research program focuses on understanding how pathogens cause disease, and is dedicated to the development of diagnostics, vaccines, and treatments to combat these emerging and re-emerging infectious disease threats. The NEIDL houses biosafety level 2 (BSL-2), BSL-3, and BSL-4 laboratories, which are designed to permit investigators to work safely with these emerging pathogens. The NEIDL is owned and operated by Boston University, but is also one component of a <a href=\"https:\/\/www.niaid.nih.gov\/research\/biocontainment-research-facilities\">national network of secure facilities that study emerging infectious diseases<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><a class=\"button-primary\" href=\"https:\/\/trusted.bu.edu\/s\/1759\/22\/form.aspx?sid=1759&amp;gid=2&amp;pgid=422&amp;cid=1060&amp;dids=1292&amp;bledit=1&amp;appealcode=WEBMED-DV\">Become A Donor<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Following the events of September 11, 2001, the lack of&#8230;<\/p>\n","protected":false},"author":15163,"featured_media":0,"parent":0,"menu_order":7,"comment_status":"closed","ping_status":"closed","template":"page-templates\/landing.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/neidl\/wp-json\/wp\/v2\/pages\/5363"}],"collection":[{"href":"https:\/\/www.bu.edu\/neidl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/neidl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/neidl\/wp-json\/wp\/v2\/users\/15163"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/neidl\/wp-json\/wp\/v2\/comments?post=5363"}],"version-history":[{"count":30,"href":"https:\/\/www.bu.edu\/neidl\/wp-json\/wp\/v2\/pages\/5363\/revisions"}],"predecessor-version":[{"id":7722,"href":"https:\/\/www.bu.edu\/neidl\/wp-json\/wp\/v2\/pages\/5363\/revisions\/7722"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/neidl\/wp-json\/wp\/v2\/media?parent=5363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}